IM Cannabis Corp. is proposing a reverse merger with Israeli biotechnology firm Kadimastem in which it would spin out – and potentially sell – its existing medical marijuana operations in Israel and Germany.

Israel’s IMC looks to spinout, sell cannabis unit in pivot to biotech sector is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs